Speakers: Christopher R. deFilippi, M.D. (Vice-Chairman of Academic Affairs at Inova Heart and Vascular Institute)
Olink
Recent Posts
Targeted discovery proteomics in cardiovascular clinical trials
Jan 27, 2022 2:00:37 PM / by Olink posted in Cardiovascular diseases, Clinical research, User group meetings
Proteomic profiling of tesamorelin in HIV-associated NAFLD
Jan 27, 2022 1:49:47 PM / by Olink posted in Proteomics, User group meetings, HIV, NAFLD
Speakers: Steven Grinspoon, M.D. (Professor of Medicine, Harvard Medical School, Chief, Metabolism Unit, MGH Endowed Chair in Neuroendocrinology and Metabolism, Director, Nutrition Obesity Research Center at Harvard)
Prognostic biomarkers for pediatric Crohn’s disease
Jan 27, 2022 1:19:13 PM / by Olink posted in Biomarkers, User group meetings, Chron's disease
Speakers: Andrés Hurtado-Loreanzo, Ph.D. (Vice President, Translational Research at Crohn's & Colitis Foundation)
Exploring molecular phenotypes of incident breast cancer through population-based proteogenomics
Dec 3, 2021 10:04:35 AM / by Olink posted in Oncology, Multiomics, Clinical research, Population based studies
Speakers: Dr. Anders Mälarstig Director of Target Sciences Pfizer Worldwide Research and Development
The right drug targets for the right patient – Using biomarkers to solve challenges in drug development
Dec 3, 2021 9:53:45 AM / by Olink posted in Multiomics, Drug discovery & development, Personalized medicine
Speakers: Dr. Jürgen Braunger of Boehringer Ingelheim Pharma, Dr. Timothy Radstake of AbbVie & Dr. Christopher D. Whelan of Biogen
Detecting Cancer Biomarkers from Proteins in Liquid Biopsy
Oct 26, 2021 4:50:05 PM / by Olink posted in Oncology, Biomarkers, Proteogenomics
Speakers: Klaus Pantel, MD Chairman and Founding Director, Institute for Tumor Biology & Christoffer Gebhardt, MD Head, University Skin Cancer Center Hamburg University of Edinburgh
Maximizing the power of proteomic clinical trial profiling for better actionable insights - a new collaborative initiative from the SCALLOP consortium
Aug 12, 2021 10:31:53 AM / by Olink posted in Multiomics, Clinical research, Drug discovery & development, Proteogenomics
Speakers: Anders Mälarstig, Direct of Target science at Pfizer
High-throughput proteomics as a keystone in multiomic approaches to COVID-19 research
Aug 12, 2021 10:31:18 AM / by Olink posted in Infectious diseases, Clinical research, Covid19
Speakers: Niklas Björkström, Associate Professor at Karolinska University Hospital & Fridtjof Lund-Johansen, MD at Oslo University Hospital
Protein biomarkers in plasma: revealing biological insights into tumor microenvironment
Aug 12, 2021 10:30:47 AM / by Olink posted in Immunotherapy, Oncology, Multiomics, Clinical research
Speakers: Genevieve Boland, Associate Professor of Surgery at Harvard Medical School & Arnav Mehta, Postdoctoral researcher in Immunology at the Broad Institute of MIT and Harvard
The Human Protein Atlas – implications for human biology, drug development and precision medicine
Aug 12, 2021 10:30:25 AM / by Olink posted in Wider proteomics studies, Wellness, Precision medicine
Speakers: Mathias Uhlén, Professor at Science for Life Laboratory and Albanova University Center, Royal Institute of Technology (KTH)